Colossal Biosciences has pushed its woolly mammoth target from 2028 into the early 2030s after discovering the effort likely requires more than 150 gene edits, not the roughly 60 previously assumed; CEO Ben Lamm told TIME there is no hard date, describing the target only as “early 2030s,” and explicitly saying it is “not 2036, but not 2030 either.” The reporting also says AI is being enlisted as part of the workflow, reflecting a broader shift from simple editing toward computationally assisted genome design.
The technical signal is that de-extinction is proving substantially harder than public timelines suggested, which matters for the Ark because it highlights three failure modes: underestimated genetic complexity, underestimated reproductive constraints, and timeline slippage driven by biology rather than software. For lunar habitation and preservation, the lesson is that closed-system life support, cryopreservation, and synthetic biology programs must be built around conservative schedules, redundant validation, and the assumption that mammalian development will be slower and more failure-prone than headline claims imply.
The Ark team should track Colossal Biosciences, its AI/genome-editing stack, and any peer-reviewed data on multi-gene mammalian editing, embryo development, and surrogate gestation success rates. Priority research should include whether AI can materially improve design of large-scale edits, what error rates remain in mammalian editing pipelines, and which preservation or de-extinction techniques could be repurposed for Ark food, medicine, and biodiversity backup systems.